Sam Roberts, New York Times; Ted Stanley, Whose Fentanyl Lollipop Treated Chronic Pain, Dies at 77
"The lollipop version was invented by Dr. Stanley and Brian I. Hague in 1983 and approved by federal regulators in 1998 to treat cancer pain under the name Actiq.
Their patent was assigned to the University of Utah Research Foundation.
The product was considered a breakthrough because it could be sucked or swabbed in the mouths of patients, including children and old people, who had an aversion to vaccinations or had difficulty swallowing pills."
Don't be fooled by potentially misleading offers and notices from private companies
Some trademark applicants and registrants have paid fees to private companies, mistakenly thinking they were paying fees required by the USPTO. We do not endorse any of these private companies and you are not required to use them.
Keep reading for information on potentially misleading offers and notices—also called solicitations—and how to identify them. You can also watch our "Solicitation Alert" video below.
On this page:
- Trademark Information Network News Video: Solicitation Alert
- What is a trademark-related solicitation?
- What kinds of trademark-related services do private companies offer?
- How can I tell the difference between potentially misleading trademark offers and notices and legitimate USPTO emails and notices?
- Are the deadlines in these offers and notices accurate?
- I received a misleading trademark offer or notice. What should I do?
- Do you have any examples of potentially misleading offers or notices?"